Newsbenzinga
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
· Published
Article summary
Axogen is acquiring BioCircuit Technologies for $200 million to add sutureless NerveTape to its portfolio, funded by a public stock offering.
An excerpt from the original article.
Comments —
Loading comments…